Management of Adverse Events Associated with Cabozantinib Therapy in Renal Cell Carcinoma
作者： Manuela Schmidinger , Romano Danesi
DOI: 10.1634/THEONCOLOGIST.2017-0335
关键词:
摘要: … High levels of AXL and MET expression in tumor tissue are … of cabozantinib, a potent inhibitor of MET, VEGFR2 and AXL, with … Simultaneous AXL and MET inhibition with cabozantinib …
core.ac.uk
oup.com
alphamedpress.org 参考文章(106)
Michael A Weitzner, Kristine A Donovan, Paul B Jacobsen, Distinguishing fatigue and depression in patients with cancer. Seminars in Clinical Neuropsychiatry. ,vol. 8, pp. 229- 240 ,(2003)
J Brandt, RA Briddell, EF Srour, TB Leemhuis, R Hoffman, Role of c-kit ligand in the expansion of human hematopoietic progenitor cells Blood. ,vol. 79, pp. 634- 641 ,(1992) , 10.1182/BLOOD.V79.3.634.634
Theresa L. Whiteside, The Role of Immune Cells in the Tumor Microenvironment Cancer treatment and research. ,vol. 130, pp. 103- 124 ,(2006) , 10.1007/0-387-26283-0_5
S. Y. Mishkin, M. A. Yalovsky, R. Pollack, S. Mishkin, H. P. Morris, Inhibition of Local and Metastatic Hepatoma Growth and Prolongation of Survival after Induction of Hypothyroidism Cancer Research. ,vol. 41, pp. 3040- 3045 ,(1981)
Livio Trusolino, Luisa Pugliese, Paolo M. Comoglio, Interactions between scatter factors and their receptors: hints for therapeutic applications The FASEB Journal. ,vol. 12, pp. 1267- 1280 ,(1998) , 10.1096/FASEBJ.12.13.1267
L Zhou, X-D Liu, M Sun, X Zhang, P German, S Bai, Z Ding, N Tannir, C G Wood, S F Matin, J A Karam, P Tamboli, K Sircar, P Rao, E B Rankin, D A Laird, A G Hoang, C L Walker, A J Giaccia, E Jonasch, Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma Oncogene. ,vol. 35, pp. 2687- 2697 ,(2016) , 10.1038/ONC.2015.343
Andrew J. Weickhardt, Robert C. Doebele, W. Thomas Purcell, Paul A. Bunn, Ana B. Oton, Micol S. Rothman, Margaret E. Wierman, Tony Mok, Sanjay Popat, Julie Bauman, Jorge Nieva, Silvia Novello, Sai-Hong Ignatius Ou, D. Ross Camidge, Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients Cancer. ,vol. 119, pp. 2383- 2390 ,(2013) , 10.1002/CNCR.28089
Yinggang Sun, Liyong Sun, Yanxin An, Xin Shen, Cabozantinib, a Novel c-Met Inhibitor, Inhibits Colorectal Cancer Development in a Xenograft Model Medical Science Monitor. ,vol. 21, pp. 2316- 2321 ,(2015) , 10.12659/MSM.893590
Ollie Minton, Alison Richardson, Michael Sharpe, Matthew Hotopf, Patrick Stone, None, Drug therapy for the management of cancer related fatigue Cochrane Database of Systematic Reviews. ,vol. 7, ,(2010) , 10.1002/14651858.CD006704.PUB3
Manuela Schmidinger, Joaquim Bellmunt, Plethora of agents, plethora of targets, plethora of side effects in metastatic renal cell carcinoma. Cancer Treatment Reviews. ,vol. 36, pp. 416- 424 ,(2010) , 10.1016/J.CTRV.2010.01.003